Navigation Links
Chroma to Present Phase I Efficacy Data for Novel Cancer Therapy CHR-2797
Date:11/30/2007

OXFORD, England, Nov. 30 /PRNewswire/ -- Chroma Therapeutics Limited announced today that it will report efficacy data from a Phase I clinical trial of its oral, once-daily experimental cancer therapy CHR-2797 at the forthcoming American Society of Hematology (ASH) meeting. CHR-2797 is the only oral aminopeptidase inhibitor currently in clinical development. The company will also be presenting the results of various preclinical studies. Details of the presentations are as follows:

Abstract # 443: oral presentation

Title: A Phase I Study of CHR-2797, an Orally Active Aminopeptidase

Inhibitor in Elderly and/or Treatment Refractory Patients with Acute

Myeloid Leukemia

Location and timing: Acute Myeloid Leukemias: Therapy, excluding

Transplantation-Novel Therapies, Rooms A411-A412: Monday December 10,

2007, 13:30-15:00 Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

Abstract # 1608, Poster # 762

Title: Cellular Aminopeptidase Inhibition as a Target for the Therapy of

AML by the Novel Agent CHR-2797

Location and timing: Poster Session I, Hall B4: Saturday, December 8,

2007, 17:30-19:30 Eastern Standard Time

Presenter: Dr Chris Jenkins (University Hospital, Cardiff, UK)

Abstract # 2505, Poster # 695

Title: Aminopeptidase Inhibition as a Targeted Treatment Strategy in

Myeloma

Location and timing: Poster Session II, Hall B4: Sunday, December 9,

2007, 18:00-20:00, Eastern Standard Time

Presenter: Dr Faith Davies (Royal Marsden Hospital, London, UK)

The ASH posters will be available at the company's website, http://www.chromatherapeutics.com following the above presentations.

Enquiries

Chroma Therapeutics Limited

Ian Nicholson Chief Executive Officer +44 (0)1235 829120'/>"/>

SOURCE Chroma Therapeutics Limited
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Chromatin remodeling complex connected to DNA damage control
2. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
3. Matrixx Initiatives, Inc. to Present at the Roth Capital Partners 2007 New York Conference
4. BD to Present at the Bear Stearns 20th Annual Healthcare Conference
5. ATS Medical to Present at the 2007 Thomas Weisel Partners Healthcare Conference
6. Omnicell to Present at Thomas Weisel Healthcare Conference 2007
7. AtriCure to Present at Roth Capital Partners 2007 New York Conference
8. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
9. MDS to Present at Thomas Weisel Partners Healthcare Conference
10. Hospira to Present at the Bear Stearns 20th Annual Healthcare Conference on September 11
11. AMICAS to Present at Thomas Weisel Partners Healthcare Conference 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/5/2015)... 2015 A Bakersfield, Calif. state court jury ... trial awarding the plaintiff Coleen M. Perry a total of ... a TVT-Abbrevo pelvic mesh sling device, manufactured by Ethicon, Inc., ... , a partner at Wagstaff & Cartmell in ... plaintiff, along with Rich Freese and Tim Goss of ...
(Date:3/5/2015)... Testosterone lawsuits ( http://www.testosteronelawsuithub.com/ ) filed ... strokes and other serious cardiovascular events due to their ... forward in the federal multidistrict litigation now underway in ... a Case Management Order issued on March 3rd, the ... master pleadings in the proceeding. Among other things, the ...
(Date:3/5/2015)... HomeCEUConnection.com is proud to support Nutrition ... their nutrition CEUs. To raise awareness on ... is offering 10% off selected nutrition CEU ... . , High Quality Continuing Education for ... continuing education courses for Physical Therapists, Physical ...
(Date:3/5/2015)... 05, 2015 SuperCloset has released a new ... series aims to teach viewers everything they need to know ... Like a SuperPro takes you from seed all the way ... clone, to how to prune Grow Like a SuperPro will ... the whole series for download for a special introductory price ...
(Date:3/5/2015)... March 05, 2015 At the ... Beyond,” leaders in addiction treatment met today in Jackson, ... best clinical practices. Among the numerous respected speakers will ... will address the role that pain medications have had ... evidence-based treatment options. , "It is hard to believe ...
Breaking Medicine News(10 mins):Health News:Client Wins $5.7 Million in TVT-Abbrevo Verdict against Johnson & Johnson in California State Court 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 2Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 3Health News:Testosterone Lawsuits Move Forward, as Bernstein Liebhard LLP Comments on Most Recent Order Issued in Federal Litigation 4Health News:HomeCEUConnection.com Offers Nutrition CEUs this March to Celebrate Nutrition Month 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 2Health News:National Addiction Treatment Expert William S. “Bill” Jacobs, Md Speaks At Prestigious 7th Annual Mississippi Addiction Conference 3
... July 10 Omnicell, Inc.,(Nasdaq: OMCL ), a leading provider of ... 21 to discuss the,company,s second quarter 2008 financial results., What: ... When: July 21, 2008, 1:30 p.m. PDT ... Rob Seim, ...
... the cancer in young men haven,t changed, study says , , ... deadliest form of skin cancer, are increasing sharply among younger ... a new study says. , "These findings are important, ... about the risks of skin cancer from sun tanning do ...
... Nutritional Wonder Hair Growth Creme & Acne Treatment Kit, ... a,staggering four million in the US alone, and the realization ... Herbalist and,Cosmetologist, Chatto Wright, has created Chatto 6 Plus Growth ... treatment which offers a solution to,the ever-increasing statistics of hair ...
... Tool Aims to Improve Genetic Healthcare and ... July 10 DNA Direct, Inc. and,Iverson ... companies will,collaborate to offer personalized reports for ... to warfarin, a,commonly used anticoagulant. DNA Direct ...
... Now Requires Screening for 28 Genetic, Metabolic Conditions, ... month by Governor Edward G. Rendell will help to ... state Health Department., By amending the Newborn Child ... of Health to continue to provide for screening and ...
... Reports Economic Activity Twice as Large as Reported Last ... ... A collaborative of Massachusetts,leading human services associations today lauded a study conducted ... state,s human services industry could be as high as,$437 million, twice as ...
Cached Medicine News:Health News:Omnicell to Release Second Quarter 2008 Earnings Results on July 21 2Health News:Melanoma Rates Soar Among Younger Women 2Health News:Melanoma Rates Soar Among Younger Women 3Health News:Video: Chatto Skincare Unprecedented Breakthrough 2Health News:Video: Chatto Skincare Unprecedented Breakthrough 3Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 2Health News:DNA Direct and Iverson Genetics Announce Partnership to Provide Personalized Patient Reports for Warfarin Dosing Test Results 3Health News:New Law Signed by Governor Rendell Expands Newborn Screening in Pennsylvania 2Health News:New Study Shows Human Services Impact May Be $430 Million 2
(Date:3/5/2015)... Mar. 05, 2015 Research and Markets ... "Japan Pharma Outlook 2015: Year to Watch out ... report to their offering. The ... from April -2014 (Annexure 1) is a game ... whether generic or innovator. The most of the companies ...
(Date:3/5/2015)... , March 5, 2015 Mallinckrodt ... global specialty biopharmaceutical company, and Ikaria, Inc. a privately-held ... into a definitive agreement under which a subsidiary of ... Dearborn -led investor group in a transaction valued at ... closing conditions, the parties expect the transaction to be ...
(Date:3/5/2015)... , Mar. 05, 2015 Research and Markets ... of the "Global Rising Stars Outlook 2015" ... for treating diseases are being sought after with fresh ... discovered. One field which is poised to bring a ... the next decades is the Stem cell therapy/Regenerative Medicine ...
Breaking Medicine Technology:Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 2Japan Pharma Outlook 2015: Year to Watch out for Authorized Generics (AGs), Biosimilars and Overseas Strategic Initiatives 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 2Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 3Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 4Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 5Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 6Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 7Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 8Mallinckrodt Pharmaceuticals To Expand Hospital Growth Platform With Ikaria, Inc. Acquisition 9Global Pharma Rising Stars Outlook 2015 2
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
Medicine Products: